AACE Endocrine Practice Journal: Published on May, 2022Nonalcoholic fatty liver disease (NAFLD) is part of a multisystemic disease and is closely associated with obesity, insulin resistance (IR), type 2 diabetes mellitus (T2D), hypertension, and atherogenic dyslipidemia. The definition of NAFLD is based on the presence of hepatic steatosis in...

AHA Journals (Circulation): Published on November, 2022Once patients have completed their dual antiplatelet therapy, we need to stop one of the medications — which one — ASA or clopidogrel? For many of us, we will keep the ASA and get rid of the other agent like clopidogrel.This study in Korea included 5438 patients who had PCI with drug-elutin...

AACE Endocrine Practice Journal: Published on May, 2022Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease affecting 25% of the global population. NAFLD is associated with cardiometabolic disorders: (1) obesity, (2) insulin resistance, (3) type 2 diabetes mellitus, (4) high blood pressure, and (5) at...